Clal Insurance Enterprises Holdings Ltd Trims Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Clal Insurance Enterprises Holdings Ltd lessened its position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 11.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 800,000 shares of the company’s stock after selling 100,000 shares during the quarter. Clal Insurance Enterprises Holdings Ltd owned 0.16% of SPDR S&P Pharmaceuticals ETF worth $35,488,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Rockport Wealth LLC bought a new stake in SPDR S&P Pharmaceuticals ETF in the second quarter worth about $1,813,000. First Citizens Bank & Trust Co. raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.5% in the third quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after buying an additional 6,227 shares during the period. AlphaMark Advisors LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth approximately $234,000. U.S. Capital Wealth Advisors LLC boosted its holdings in SPDR S&P Pharmaceuticals ETF by 44.1% during the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 18,066 shares of the company’s stock valued at $719,000 after acquiring an additional 5,531 shares during the period. Finally, CX Institutional grew its position in SPDR S&P Pharmaceuticals ETF by 117.2% in the 2nd quarter. CX Institutional now owns 9,711 shares of the company’s stock valued at $386,000 after acquiring an additional 5,240 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 0.5 %

XPH stock opened at $46.57 on Friday. The firm has a market cap of $225.86 million, a price-to-earnings ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a twelve month low of $36.49 and a twelve month high of $48.76. The business’s fifty day simple moving average is $45.53 and its two-hundred day simple moving average is $42.98.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.